COVID antiviral Paxlovid to see worth enhance following 400% vaccine hike
Enlarge / A field of Paxlovid, the Pfizer antiviral drug. (credit score: Getty | Europa Press Information) After elevating the value of COVID-19 vaccines greater than fourfold this yr, Pfizer CEO Albert Bourla advised buyers Monday that the corporate can